Your browser does not support JavaScript or it may be disabled!
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
Get Realtime News
on your webpage

About 404 results for "nexium"

Ranbaxy loses appeal on approvals, exclusivity of 2 drugs in US

Ranbaxy loses appeal on approvals, exclusivity of 2 drugs in US

In November, Ranbaxy had sued USFDA over revoking an approval to sell generic versions of Nexium and Valcyte in the US. Photo: Pradeep Gaur/Mint New Delhi: Ranbaxy Laboratories tentative approvals for its generic versions of digestive disorder ..., 1 month ago
Ranbaxy loses US appeal on Nexium, Valcyte generics Hindu Business Line, 1 month ago

151 images for nexium

ISO, 3 weeks ago
ISO, 3 weeks ago
ISO, 3 weeks ago
ISO, 3 weeks ago
ISO, 3 weeks ago
ISO, 3 weeks ago
ISO, 3 weeks ago
ISO, 3 weeks ago
ISO, 3 weeks ago
ISO, 3 weeks ago

U.S. Judge Denies Ranbaxy Bid to Reinstate Approvals for Valcyte, Nexium Copies

Reuters Health Information By Reuters Staff March03,2015 MUMBAI (Reuters) - A U.S. federal judge has denied Indian generic drugmaker Ranbaxy Laboratories Ltd's bid to reinstate approvals granted to it to launch the first copies of the heartburn ...
 Diabetes Care1 month ago US judge denies Ranbaxy to launch Valcyte, Nexium copy  Economic Times1 month ago US judge denies Ranbaxy bid to reinstate approvals for Valcyte, Nexium copies  Smart Investor1 month ago Ranbaxy denied bid to reinstate approvals for Valcyte, Nexium copies  Hindu Business Line1 month ago

Expect FY16 US generic launch for Nexium: Lupin

In an interview with CNBC-TV18, CFO S Ramesh spoke to Latha Venkatesh and Sonia Shenoy about a recent acquisition and other developments such as a recent FDA audit at its Indore facility as well as its plans to launch a generic version of the world’s ...
 Money Control1 month ago

Ranbaxy loses generic exclusivity over $6 billion Nexium market

Drugmaker Ranbaxy on Tuesday said that the US Food and Drug Administration (FDA) has determined that the Indian drug manufacturer has forfeited its 180-day exclusivity to sell generic version of AstraZeneca Plc's heartburn drug Nexium in the US market.
 DNA2 months ago Ranbaxy loses exclusivity on heartburn drug in US  Business Standard2 months ago Teva to gain post Ranbaxy's exclusivity loss for Nexium  Money Control2 months ago Cipla surges to record high on generic Nexium supply hopes  Economic Times2 months ago
The Telegraph

US court quashes Ranbaxy's plea against FDA on Nexium, Valcyte generic

A US court has dismissed a plea by Ranbaxy challenging the American drug regulator's move to revoke the 180-day exclusivity granted to the Indian pharma major for selling low-cost copies of two blockbuster drugs—AstraZeneca's Nexium and Roche AG's ...
 VC Circle1 month ago 'Ranbaxy's Nexium generic loss may up Cipla's EPS 3-5%'  Money Control2 months ago Ranbaxy suffers fresh jolt  The Telegraph2 months ago

Stock diagnosis: Is Cipla a good buy for investors post Q3?

According to analysts, rollout of inhalers in Europe and supplies of esomeprazole (Nexium) to Teva will be key triggers for the stock in coming quarters. Currently, the company sells Salmeterol Fluticasone inhaler device across five countries. The company ...
 Economic Times2 months ago

Dr Reddy's falls 2.5%; Credit Suisse cuts to "neutral"

The reason behind downgrade was delay in monetisation of key drugs such as Nexium and Copaxone, which implies low-teen FY16 EPS growth, said Credit Suisse. Brokerage expects possibility of adverse US FDA action against company's Srikakulam facility in south ...
 Economic Times2 months ago

Ranbaxy forfeits 180 days exclusivity for generic Nexium

f India | New Delhi January 27, 2015 Last Updated at 18:35 IST Related News Ranbaxy forfeits 180 days exclusivity for stomach drugs In a fresh setback, Ranbaxy today said US health regulator FDA has determined that the drug maker has forfeited its 180-day ...
 Business Standard2 months ago
FDA News

Medicare Set-Aside Update: Generic Nexium and Its Impact on MSAs

, the FDA approved esomeprazole, the generic form of Nexium. Claims payers and the Medicare Set-Aside (MSA) industry take notice any time a widely prescribed brand-name drug becomes available as a generic. The impact of generic availability, if not ...
 ISO3 weeks ago Pharmacy Today, March 2015  Pharmacist.com1 month ago Showcase, March 2015  Pharmacist.com1 month ago Mylan Denied Final Generic Nexium Approval  FDA News2 months ago
Money Today

Ranbaxy loses exclusive rights to produce generic Nexium

PTI New Delhi Last Updated: January 27, 2015 | 14:07 IST (Photo: Reuters) Ranbaxy, the home-grown drug major, on Tuesday said that the US Food and Drug Administration (US FDA) has determined that the company has forfeited its 180 days exclusivity for stomach ...
 Money Today2 months ago
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts


Realtime News

on your Webpage

Add Widget >Get your members hooked!
Related Queries - nexium
Get updated on latest news & your favorite topics right in your inbox!
More     Less